Tania Chander BS, PharmD

Tania joined Curis in 2013 as the Vice President of Product Development and Program Management responsible for portfolio strategy and operational excellence. She has over 15 years of biopharmaceutical experience in early and late stage clinical development across multiple therapeutic areas, primarily in Oncology.
Tania has extensive knowledge and expertise in clinical planning, including protocol design, site selection, recruitment and data analysis. Prior to Curis, she held positions at Medimmune and Bristol-Myers Squibb in Program Leadership, Program Management, Scientific Communications and Medical Strategy. She received her Bachelor and Doctor of Pharmacy degrees from Rutgers University.